Fredun Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. L

A side-by-side comparison of Fredun Pharmaceuticals Ltd (539730) and APOLLO HOSPITALS ENTER. L (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads 539730 vs APOLLOHOSP on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability13
  • Growth20
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

100.39
P/E ratio
64.48
9.14
P/B ratio
12.55
0.05%
Dividend yield
0.22%
₹14.65
EPS
₹135.04

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.80%
Return on equity
21.20%
19.00%
Return on capital
17.00%
12.00%
EBITDA margin
15.00%
4.63%
Net margin
7.94%

Growth

539730 takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

32.46%
Revenue CAGR (3Y)
14.94%
43.64%
Profit CAGR (3Y)
33.39%

Size & financial health

APOLLOHOSP takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2,470 Cr
Market cap
₹1.25L Cr
₹454 Cr
Revenue
₹25,228 Cr
₹21 Cr
Net profit
₹2,003 Cr
0.80
Debt / equity
0.32
Fredun Pharmaceuticals Ltd
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 75.2% CAGR over last 5 years", "Debtor days have improved from 87.9 to 53.2 days.", "Company's median sales growth is 28.6% of last 10 years"]
  • ["Stock is trading at 8.65 times its book value", "Promoter holding has decreased over last 3 years: -5.05%"]
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Fredun Pharmaceuticals Ltd full analysis APOLLO HOSPITALS ENTER. L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.